{"id":"https://openalex.org/W2128449202","doi":"https://doi.org/10.1158/1078-0432.ccr-04-1494","title":"Phase I Study of a Novel Taxane BMS-188797 in Adult Patients with Solid Malignancies","display_name":"Phase I Study of a Novel Taxane BMS-188797 in Adult Patients with Solid Malignancies","publication_year":2005,"publication_date":"2005-05-01","ids":{"openalex":"https://openalex.org/W2128449202","doi":"https://doi.org/10.1158/1078-0432.ccr-04-1494","mag":"2128449202","pmid":"https://pubmed.ncbi.nlm.nih.gov/15867232"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.ccr-04-1494","doi":"https://doi.org/10.1158/1078-0432.ccr-04-1494","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-04-1494","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5086094365","display_name":"Christopher R. Garrett","orcid":"https://orcid.org/0000-0003-2564-7882","observed_orcids":["https://orcid.org/0000-0003-2564-7882"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christopher R. Garrett","raw_affiliation_strings":["1Experimental Therapeutics and Phase I Programs, Department of Interdisciplinary Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Experimental Therapeutics and Phase I Programs, Department of Interdisciplinary Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida and","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005003137","display_name":"Mayer Fishman","orcid":"https://orcid.org/0000-0003-0185-1432","observed_orcids":["https://orcid.org/0000-0003-0185-1432"]},"institutions":[{"id":"https://openalex.org/I2613432","display_name":"University of South Florida","ror":"https://ror.org/032db5x82","country_code":"US","type":"education","lineage":["https://openalex.org/I2613432"]},{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mayer N. Fishman","raw_affiliation_strings":["1Experimental Therapeutics and Phase I Programs, Department of Interdisciplinary Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida and","University of South FLorida"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Experimental Therapeutics and Phase I Programs, Department of Interdisciplinary Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida and","institution_ids":["https://openalex.org/I3019308854"]},{"raw_affiliation_string":"University of South FLorida","institution_ids":["https://openalex.org/I2613432"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037983640","display_name":"Randall R. Rago","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2613432","display_name":"University of South Florida","ror":"https://ror.org/032db5x82","country_code":"US","type":"education","lineage":["https://openalex.org/I2613432"]},{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Randall R. Rago","raw_affiliation_strings":["1Experimental Therapeutics and Phase I Programs, Department of Interdisciplinary Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida and","University of South FLorida"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Experimental Therapeutics and Phase I Programs, Department of Interdisciplinary Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida and","institution_ids":["https://openalex.org/I3019308854"]},{"raw_affiliation_string":"University of South FLorida","institution_ids":["https://openalex.org/I2613432"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062655853","display_name":"Charles C. Williams","orcid":"https://orcid.org/0000-0002-3698-1555","observed_orcids":["https://orcid.org/0000-0002-3698-1555"]},"institutions":[{"id":"https://openalex.org/I2613432","display_name":"University of South Florida","ror":"https://ror.org/032db5x82","country_code":"US","type":"education","lineage":["https://openalex.org/I2613432"]},{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Charles C. Williams","raw_affiliation_strings":["1Experimental Therapeutics and Phase I Programs, Department of Interdisciplinary Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida and","University of South FLorida"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Experimental Therapeutics and Phase I Programs, Department of Interdisciplinary Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida and","institution_ids":["https://openalex.org/I3019308854"]},{"raw_affiliation_string":"University of South FLorida","institution_ids":["https://openalex.org/I2613432"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021777594","display_name":"Anne M. Dellaportas","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2613432","display_name":"University of South Florida","ror":"https://ror.org/032db5x82","country_code":"US","type":"education","lineage":["https://openalex.org/I2613432"]},{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anne M. Dellaportas","raw_affiliation_strings":["1Experimental Therapeutics and Phase I Programs, Department of Interdisciplinary Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida and","University of South FLorida"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Experimental Therapeutics and Phase I Programs, Department of Interdisciplinary Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida and","institution_ids":["https://openalex.org/I3019308854"]},{"raw_affiliation_string":"University of South FLorida","institution_ids":["https://openalex.org/I2613432"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057204740","display_name":"John J. Mahany","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2613432","display_name":"University of South Florida","ror":"https://ror.org/032db5x82","country_code":"US","type":"education","lineage":["https://openalex.org/I2613432"]},{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. Joseph Mahany","raw_affiliation_strings":["1Experimental Therapeutics and Phase I Programs, Department of Interdisciplinary Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida and","University of South FLorida"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Experimental Therapeutics and Phase I Programs, Department of Interdisciplinary Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida and","institution_ids":["https://openalex.org/I3019308854"]},{"raw_affiliation_string":"University of South FLorida","institution_ids":["https://openalex.org/I2613432"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111718623","display_name":"Richard M. Lush","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2613432","display_name":"University of South Florida","ror":"https://ror.org/032db5x82","country_code":"US","type":"education","lineage":["https://openalex.org/I2613432"]},{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Richard M. Lush","raw_affiliation_strings":["1Experimental Therapeutics and Phase I Programs, Department of Interdisciplinary Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida and","University of South FLorida"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Experimental Therapeutics and Phase I Programs, Department of Interdisciplinary Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida and","institution_ids":["https://openalex.org/I3019308854"]},{"raw_affiliation_string":"University of South FLorida","institution_ids":["https://openalex.org/I2613432"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056492087","display_name":"William S. Dalton","orcid":"https://orcid.org/0000-0003-2582-0454","observed_orcids":["https://orcid.org/0000-0003-2582-0454"]},"institutions":[{"id":"https://openalex.org/I2613432","display_name":"University of South Florida","ror":"https://ror.org/032db5x82","country_code":"US","type":"education","lineage":["https://openalex.org/I2613432"]},{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"William S. Dalton","raw_affiliation_strings":["1Experimental Therapeutics and Phase I Programs, Department of Interdisciplinary Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida and","University of South FLorida"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Experimental Therapeutics and Phase I Programs, Department of Interdisciplinary Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida and","institution_ids":["https://openalex.org/I3019308854"]},{"raw_affiliation_string":"University of South FLorida","institution_ids":["https://openalex.org/I2613432"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041301470","display_name":"Ashwin M. Gollerkeri","orcid":"https://orcid.org/0000-0001-8215-4318","observed_orcids":["https://orcid.org/0000-0001-8215-4318"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ashwin Gollerkeri","raw_affiliation_strings":["2Bristol-Myers Squibb, Philadelphia, PA","BRISTOL MYERS-SQUIBB"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Bristol-Myers Squibb, Philadelphia, PA","institution_ids":["https://openalex.org/I4210091812"]},{"raw_affiliation_string":"BRISTOL MYERS-SQUIBB","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109356119","display_name":"Marvin B. Cohen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marvin B. Cohen","raw_affiliation_strings":["2Bristol-Myers Squibb, Philadelphia, PA","BRISTOL MYERS-SQUIBB"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Bristol-Myers Squibb, Philadelphia, PA","institution_ids":["https://openalex.org/I4210091812"]},{"raw_affiliation_string":"BRISTOL MYERS-SQUIBB","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5102841436","display_name":"Daniel M. Sullivan","orcid":"https://orcid.org/0009-0003-0951-9781","observed_orcids":["https://orcid.org/0009-0003-0951-9781","https://orcid.org/0000-0002-2183-1773"]},"institutions":[{"id":"https://openalex.org/I2613432","display_name":"University of South Florida","ror":"https://ror.org/032db5x82","country_code":"US","type":"education","lineage":["https://openalex.org/I2613432"]},{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel M. Sullivan","raw_affiliation_strings":["1Experimental Therapeutics and Phase I Programs, Department of Interdisciplinary Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida and","University of South FLorida"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Experimental Therapeutics and Phase I Programs, Department of Interdisciplinary Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida and","institution_ids":["https://openalex.org/I3019308854"]},{"raw_affiliation_string":"University of South FLorida","institution_ids":["https://openalex.org/I2613432"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.6217,"has_fulltext":false,"cited_by_count":10,"citation_normalized_percentile":{"value":0.70643447,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":96},"biblio":{"volume":"11","issue":"9","first_page":"3335","last_page":"3341"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/taxanes","display_name":"taxanes","score":0.6079999804496765},{"id":"https://openalex.org/keywords/paclitaxel-derivatives","display_name":"paclitaxel derivatives","score":0.6100000143051147},{"id":"https://openalex.org/keywords/solid-tumors","display_name":"solid tumors","score":0.7360000014305115},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.9269999861717224},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8550000190734863},{"id":"https://openalex.org/keywords/febrile-neutropenia","display_name":"febrile neutropenia","score":0.925000011920929},{"id":"https://openalex.org/keywords/sensory-neuropathy","display_name":"sensory neuropathy","score":0.8730000257492065},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.9359999895095825},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.7559999823570251},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.9909999966621399},{"id":"https://openalex.org/keywords/renal-cell-carcinoma","display_name":"renal cell carcinoma","score":0.9980000257492065},{"id":"https://openalex.org/keywords/single-agent-chemotherapy","display_name":"single-agent chemotherapy","score":0.6880000233650208},{"id":"https://openalex.org/keywords/recommended-phase-ii-dose","display_name":"recommended phase 2 dose","score":0.7039999961853027}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8750549554824829},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.7317519783973694},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.5977081060409546},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.5579584240913391},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.5403291583061218},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.4927823841571808},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.47452035546302795},{"id":"https://openalex.org/C2778850193","wikidata":"https://www.wikidata.org/wiki/Q3775974","display_name":"Febrile neutropenia","level":4,"score":0.4734594225883484},{"id":"https://openalex.org/C2777472916","wikidata":"https://www.wikidata.org/wiki/Q1164529","display_name":"Renal cell carcinoma","level":2,"score":0.4454291760921478},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4258442223072052},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.42522621154785156},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.4203360676765442},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.39099961519241333},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3835894465446472},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.357322633266449}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007262","descriptor_name":"Infusions, Intravenous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015331","descriptor_name":"Cohort Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019540","descriptor_name":"Area Under Curve","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D043823","descriptor_name":"Taxoids","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D043823","descriptor_name":"Taxoids","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D043823","descriptor_name":"Taxoids","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1158/1078-0432.ccr-04-1494","doi":"https://doi.org/10.1158/1078-0432.ccr-04-1494","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-04-1494","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},{"id":"pmid:15867232","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15867232","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical cancer research : an official journal of the American Association for Cancer Research","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9922999739646912,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":16,"referenced_works":["https://openalex.org/W177832896","https://openalex.org/W1121095085","https://openalex.org/W1674191906","https://openalex.org/W1983066177","https://openalex.org/W1992436250","https://openalex.org/W2021885202","https://openalex.org/W2024930414","https://openalex.org/W2037605675","https://openalex.org/W2128848742","https://openalex.org/W2139248078","https://openalex.org/W2141258764","https://openalex.org/W2411778544","https://openalex.org/W2462166907","https://openalex.org/W2491374885","https://openalex.org/W4255152173","https://openalex.org/W4255762755"],"related_works":["https://openalex.org/W2149737218","https://openalex.org/W1674191906","https://openalex.org/W2134417139","https://openalex.org/W2244116267","https://openalex.org/W2142748136","https://openalex.org/W1892438397","https://openalex.org/W2279349940","https://openalex.org/W7222792866","https://openalex.org/W2076048091","https://openalex.org/W2125345656"],"abstract_inverted_index":{"PURPOSE:":[0],"Preclinical":[1],"studies":[2],"show":[3],"that":[4],"BMS-188797":[5,39,46,212,222],"has":[6],"a":[7,24,86,94,148,158,224],"broad":[8],"spectrum":[9],"of":[10,38,64,96,99,104,166,211,221],"antitumor":[11],"activity":[12],"in":[13,14,76,82,108,122,136,141,147,157,207],"vitro":[15],"cytotoxicity":[16],"assays":[17],"and":[18,35,155,178,183],"tumor":[19],"xenograft":[20],"models.":[21],"We":[22],"did":[23],"phase":[25,218],"I":[26],"trial":[27],"designed":[28],"to":[29,57,85,117],"determine":[30],"the":[31,36,73,112,132,167],"maximum":[32],"tolerated":[33],"dose":[34,62,75,220],"pharmacokinetics":[37],"when":[40],"administered":[41,48,234],"i.v.":[42,49,230],"MATERIALS":[43],"AND":[44],"METHODS:":[45],"was":[47,67,213],"over":[50],"60":[51],"minutes":[52],"once":[53],"every":[54,235],"21":[55],"days":[56],"51":[58],"patients.":[59],"The":[60,101,164,204,216],"initial":[61],"cohort":[63],"3.75":[65],"mg/m(2)":[66,114,197,229],"set":[68],"at":[69,111,193,200],"approximately":[70],"one":[71,146,156],"third":[72],"lethal":[74],"dogs.":[77],"Doses":[78],"were":[79,171],"subsequently":[80],"escalated":[81],"cohorts":[83],"according":[84],"modified":[87],"Fibonacci":[88],"design.":[89],"RESULTS:":[90],"Fifty-one":[91],"patients":[92,110,124],"received":[93],"total":[95],"160":[97],"cycles":[98],"therapy.":[100],"dose-limiting":[102,205],"toxicity":[103,206],"febrile":[105,214],"neutropenia":[106],"occurred":[107,121],"two":[109,140],"200":[113],"cohort.":[115],"Moderate":[116],"severe":[118],"sensory":[119],"neuropathy":[120],"12":[123],"(24%).":[125],"Four":[126],"radiographic":[127],"partial":[128,168],"responses":[129,169],"based":[130],"on":[131],"Response":[133],"Evaluation":[134],"Criteria":[135],"Solid":[137],"Tumors":[138],"occurred:":[139],"subjects":[142],"with":[143,150,160],"breast":[144],"cancer,":[145,154],"subject":[149,159],"non-small":[151],"cell":[152,162,175,187],"lung":[153,188],"renal":[161],"carcinoma.":[163],"duration":[165],"observed":[170],"24.1":[172],"months":[173,180,185],"(renal":[174],"carcinoma),":[176],"5.7":[177],"4.3":[179],"(breast":[181],"cancer),":[182],"4.5":[184],"(non-small":[186],"cancer).":[189],"Pharmacokinetics":[190],"appear":[191],"linear":[192],"doses":[194],"through":[195],"110":[196],"but":[198],"not":[199],"higher":[201],"doses.":[202],"CONCLUSION:":[203],"this":[208],"single-agent":[209],"study":[210],"neutropenia.":[215],"recommended":[217],"II":[219],"as":[223],"single":[225],"agent":[226],"is":[227],"175":[228],"for":[231],"1":[232],"hour":[233],"3":[236],"weeks.":[237]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}